Sign in

CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
113516358
Phone
(984) 884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
  1. 8-K Event Shareholder vote results
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. SC 13D/A Stake Beneficial Ownership Report
  8. 4 Insider Changes in Ownership
  9. SC 13D/A Stake Beneficial Ownership Report
  10. 10-Q Report Quarterly Report
  11. ARS Other Annual Report to Security Holders
  12. DEF 14A Proxy Proxy Statement
  13. 4 Insider Changes in Ownership
  14. 8-K Event Material agreement · Regulation FD disclosure
  15. 424B5 Offering Prospectus
  16. 10-K/A Report 10-K/A
  17. UPLOAD Other SEC-generated Letter
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. 10-K Report Annual Report

Page 42 of 54 · 1,070 filings